Notably, our study is the first to demonstrate that PEA exerts its antifibrotic effects in pulmonary fibrosis by inhibiting the TGF-β/Smad signaling pathway, thus aligning with previously reported mechanisms through which PEA mitigates other fibrotic diseases. Here, TGFB1 is linked to pulmonary fibrosis.